These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37446051)

  • 1. Structurally and Morphologically Distinct Pathological Tau Assemblies Differentially Affect GVB Accumulation.
    Jorge-Oliva M; van Weering JRT; Scheper W
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulovacuolar degeneration bodies are neuron-selective lysosomal structures induced by intracellular tau pathology.
    Wiersma VI; van Ziel AM; Vazquez-Sanchez S; Nölle A; Berenjeno-Correa E; Bonaterra-Pastra A; Clavaguera F; Tolnay M; Musters RJP; van Weering JRT; Verhage M; Hoozemans JJM; Scheper W
    Acta Neuropathol; 2019 Dec; 138(6):943-970. PubMed ID: 31456031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulovacuolar degeneration bodies are independently induced by tau and α-synuclein pathology.
    Jorge-Oliva M; Smits JFM; Wiersma VI; Hoozemans JJM; Scheper W
    Alzheimers Res Ther; 2022 Dec; 14(1):187. PubMed ID: 36517915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulovacuolar degeneration bodies: red alert for neurons with MAPT/tau pathology.
    Wiersma VI; Scheper W
    Autophagy; 2020 Jan; 16(1):173-175. PubMed ID: 31613164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relation between tau pathology and granulovacuolar degeneration of neurons.
    Puladi B; Dinekov M; Arzberger T; Taubert M; Köhler C
    Neurobiol Dis; 2021 Jan; 147():105138. PubMed ID: 33069844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Untangling the origin and function of granulovacuolar degeneration bodies in neurodegenerative proteinopathies.
    Wiersma VI; Hoozemans JJM; Scheper W
    Acta Neuropathol Commun; 2020 Sep; 8(1):153. PubMed ID: 32883341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuron-selective toxicity of tau peptide in a cell culture model of neurodegenerative tauopathy: essential role for aggregation in neurotoxicity.
    Zhao K; Ippolito G; Wang L; Price V; Kim MH; Cornwell G; Fulenchek S; Breen GA; Goux WJ; D'Mello SR
    J Neurosci Res; 2010 Nov; 88(15):3399-413. PubMed ID: 20882568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.
    Boluda S; Iba M; Zhang B; Raible KM; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2015 Feb; 129(2):221-37. PubMed ID: 25534024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies.
    Vingtdeux V; Davies P; Dickson DW; Marambaud P
    Acta Neuropathol; 2011 Mar; 121(3):337-49. PubMed ID: 20957377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human tauopathy-derived tau strains determine the substrates recruited for templated amplification.
    Tarutani A; Miyata H; Nonaka T; Hasegawa K; Yoshida M; Saito Y; Murayama S; Robinson AC; Mann DMA; Tomita T; Hasegawa M
    Brain; 2021 Sep; 144(8):2333-2348. PubMed ID: 33693528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylated tau immunoreactivity of granulovacuolar bodies (GVB) of Alzheimer's disease: localization of two amino terminal tau epitopes in GVB.
    Dickson DW; Liu WK; Kress Y; Ku J; DeJesus O; Yen SH
    Acta Neuropathol; 1993; 85(5):463-70. PubMed ID: 7684177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphiphysin-1 protein level changes associated with tau-mediated neurodegeneration.
    De Jesús-Cortés HJ; Nogueras-Ortiz CJ; Gearing M; Arnold SE; Vega IE
    Neuroreport; 2012 Nov; 23(16):942-6. PubMed ID: 22975846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies.
    Giacomini C; Koo CY; Yankova N; Tavares IA; Wray S; Noble W; Hanger DP; Morris JDH
    Acta Neuropathol Commun; 2018 May; 6(1):37. PubMed ID: 29730992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tauopathies and tau oligomers.
    Takashima A
    J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease of neuronal FKBP4/FKBP52 modulates perinuclear lysosomal positioning and MAPT/Tau behavior during MAPT/Tau-induced proteotoxic stress.
    Chambraud B; Daguinot C; Guillemeau K; Genet M; Dounane O; Meduri G; Poüs C; Baulieu EE; Giustiniani J
    Autophagy; 2021 Nov; 17(11):3491-3510. PubMed ID: 33459145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assembly of filamentous tau aggregates in human neuronal cells.
    Ko LW; Rush T; Sahara N; Kersh JS; Easson C; Deture M; Lin WL; Connor YD; Yen SH
    J Alzheimers Dis; 2004 Dec; 6(6):605-22; discussion 673-81. PubMed ID: 15665401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain.
    Narasimhan S; Guo JL; Changolkar L; Stieber A; McBride JD; Silva LV; He Z; Zhang B; Gathagan RJ; Trojanowski JQ; Lee VMY
    J Neurosci; 2017 Nov; 37(47):11406-11423. PubMed ID: 29054878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of mouse models to study cell-to-cell transmission of pathological tau.
    Narasimhan S; Lee VMY
    Methods Cell Biol; 2017; 141():287-305. PubMed ID: 28882308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.